Suppr超能文献

相似文献

2
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.
Cancer Chemother Pharmacol. 2004 Dec;54(6):475-86. doi: 10.1007/s00280-004-0853-7. Epub 2004 Jul 29.
7
Generation of High-Quality Pharmacokinetic Data From Parallel Tail Vein Dosing And Bleeding in Non-cannulated Rats.
J Pharm Sci. 2021 Oct;110(10):3491-3499. doi: 10.1016/j.xphs.2021.06.020. Epub 2021 Jun 12.
9
Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.
Anal Chem. 2014 Aug 19;86(16):8473-80. doi: 10.1021/ac502217r. Epub 2014 Aug 8.
10
High-throughput analysis of standardized pharmacokinetic studies in the rat using sample pooling and UPLC-MS/MS.
J Pharm Biomed Anal. 2011 Jul 15;55(5):1120-6. doi: 10.1016/j.jpba.2011.03.042. Epub 2011 Apr 6.

引用本文的文献

1
Structure-Activity Relationship Studies of Antimalarial Proteasome Inhibitors─Part II.
J Med Chem. 2023 Jan 26;66(2):1484-1508. doi: 10.1021/acs.jmedchem.2c01651. Epub 2023 Jan 11.
3
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.
ACS Omega. 2018 Oct 31;3(10):14076-14086. doi: 10.1021/acsomega.8b01625. Epub 2018 Oct 25.
4
Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales.
PLoS One. 2017 May 4;12(5):e0176571. doi: 10.1371/journal.pone.0176571. eCollection 2017.
6
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
Biochem Pharmacol. 2015 Dec 15;98(4):718-31. doi: 10.1016/j.bcp.2015.10.013. Epub 2015 Oct 19.
7
The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.
Drug Metab Dispos. 2015 May;43(5):788-802. doi: 10.1124/dmd.115.063339. Epub 2015 Mar 11.
8
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
Bioorg Med Chem Lett. 2013 Jan 15;23(2):417-21. doi: 10.1016/j.bmcl.2012.11.084. Epub 2012 Dec 1.
10
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
Bioorg Med Chem Lett. 2012 Jan 1;22(1):601-5. doi: 10.1016/j.bmcl.2011.10.074. Epub 2011 Oct 28.

本文引用的文献

1
Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.
Annu Rev Pharmacol Toxicol. 2005;45:311-33. doi: 10.1146/annurev.pharmtox.45.120403.095920.
2
Genetically modified mouse models for pharmacogenomic research.
Nat Rev Genet. 2004 Sep;5(9):657-63. doi: 10.1038/nrg1429.
3
Whatever happened to cassette-dosing pharmacokinetics?
Drug Discov Today. 2004 Aug 1;9(15):652-8. doi: 10.1016/S1359-6446(04)03137-X.
7
Chemical substructures in drug discovery.
Drug Discov Today. 2003 Jul 1;8(13):594-602. doi: 10.1016/s1359-6446(03)02740-5.
8
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
Drug Metab Dispos. 2003 Jul;31(7):846-53. doi: 10.1124/dmd.31.7.846.
9
Hit and lead generation: beyond high-throughput screening.
Nat Rev Drug Discov. 2003 May;2(5):369-78. doi: 10.1038/nrd1086.
10
A new generic column switching system for quantitation in cassette dosing using LC/MS/MS.
J Pharm Biomed Anal. 2003 Apr 10;31(6):1089-99. doi: 10.1016/s0731-7085(02)00649-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验